NYSE · Financials
Elevance Health, Inc. (ELV)
As-reported financials and recent SEC filings for Elevance Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$199.13B
Net income
$5.66B
Net margin
2.8%
Diluted EPS
$25.21
ROE
12.9%
P/E (TTM)
17.1×
Market cap
$87.75B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $199.13B | $177.01B | $171.34B | $156.59B | $138.64B |
| Gross profit | — | — | — | — | — |
| Operating income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B |
| Net income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| Diluted EPS | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-05-20
View on EDGAR →1442026-05-19
View on EDGAR →42026-05-15
View on EDGAR →42026-05-15
View on EDGAR →42026-05-15
View on EDGAR →42026-05-15
View on EDGAR →42026-05-15
View on EDGAR →42026-05-15
View on EDGAR →Go deeper on ELV
Search Elevance Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.